This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1974 Nov;134(5):883-8.

doi: 10.1001/archinte.134.5.883.

1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy

A S Brickman, D J Sherrard, J Jowsey, F R Singer, D J Baylink, N Maloney, S G Massry, A W Norman, J W Coburn

PMID: 4613310
DOI: 10.1001/archinte.134.5.883

Clinical Trial

1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy

A S Brickman et al. Arch Intern Med. 1974 Nov.

. 1974 Nov;134(5):883-8.

doi: 10.1001/archinte.134.5.883.

Authors

A S Brickman, D J Sherrard, J Jowsey, F R Singer, D J Baylink, N Maloney, S G Massry, A W Norman, J W Coburn

PMID: 4613310
DOI: 10.1001/archinte.134.5.883

No abstract available

PubMed Disclaimer

Similar articles

Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
Massry SG, Goldstein DA, Malluche HH. Massry SG, et al. Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154. Kidney Int. 1980. PMID: 7014981 Review. No abstract available.
Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
Coburn JW, Brickman AS. Coburn JW, et al. Adv Exp Med Biol. 1978;103:473-86. doi: 10.1007/978-1-4684-7758-0_48. Adv Exp Med Biol. 1978. PMID: 362852 Review. No abstract available.
The clinical use of synthetic 1,25-dihydroxycholecalciferol.
Evans IM, Boulton-Jones M, Doyle FH, Joplin GF, Lockwood M, Matthews EW, MacIntyre I. Evans IM, et al. Calcif Tissue Res. 1976 Aug;21 Suppl:236-41. Calcif Tissue Res. 1976. PMID: 782663 Clinical Trial. No abstract available.
Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
Brickman AS, Coburn JW, Norman AW, Massry SG. Brickman AS, et al. Am J Med. 1974 Jul;57(1):28-33. doi: 10.1016/0002-9343(74)90764-5. Am J Med. 1974. PMID: 4600292 Review. No abstract available.
Long-term therapy of uremic osteodystrophy in adults with calcitriol.
Moorthy AV, Harrington AR, Mazess RB, Simpson DP. Moorthy AV, et al. Clin Nephrol. 1981 Aug;16(2):93-100. Clin Nephrol. 1981. PMID: 6894893

See all similar articles

Cited by

Role of parathyroid hormone in the pathogenesis of the uremic manifestations.
Massry SG. Massry SG. Klin Wochenschr. 1979 Oct 1;57(19):1085-8. doi: 10.1007/BF01479995. Klin Wochenschr. 1979. PMID: 392183 Review.
"Ideal" parathyroid hormone in erythropoietin-stimulating agents-resistant anemia.
Ashraf B, Bat T, Weinberg OK, Moe OW, Ibrahim I. Ashraf B, et al. EJHaem. 2021 Nov 24;3(1):159-162. doi: 10.1002/jha2.316. eCollection 2022 Feb. EJHaem. 2021. PMID: 35846199 Free PMC article.
[Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].
Bulla M, Delling G, Benz-Bohm G, Stock GJ, Sánchez de Reutter A, Ziegler R, Lühmann H, Severin M, Kalbitzer E, Manegold C. Bulla M, et al. Klin Wochenschr. 1980 May 16;58(10):511-9. doi: 10.1007/BF01477068. Klin Wochenschr. 1980. PMID: 7392529 German.
Serum calcium and phosphate concentrations and parathyroid morphology in rats treated with vitamin D metabolites.
Boquist L, Larsson SE, Lorentzon R. Boquist L, et al. Urol Res. 1980;8(3):181-7. doi: 10.1007/BF00256415. Urol Res. 1980. PMID: 7423698
Pharmacology and therapeutic use of vitamin D and its analogues.
Pierides AM. Pierides AM. Drugs. 1981 Apr;21(4):241-56. doi: 10.2165/00003495-198121040-00001. Drugs. 1981. PMID: 6262039 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems